Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Tuesday, November 19, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Tuesday, November 19, 2024 | Latest Paper
Subscribe Now

TRENDING:

Chukwunonso Nwabufo

Prescription for change: diversity’s missing link in Canada’s health-care system

  • If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent
Opinion | BY CHUKWUNONSO NWABUFO | March 7, 2024
Several studies have shown that personalizing patient treatments based on their unique genotype can improve treatment outcomes, minimize adverse drug effects, and save health-care costs, writes Chukwunonso Nwabufo. Image courtesy of Pexels/Pixabay

Prescription for change: diversity’s missing link in Canada’s health-care system

Opinion | BY CHUKWUNONSO NWABUFO | March 7, 2024
  • If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent

Prescription for change: diversity’s missing link in Canada’s health-care system

Opinion | BY CHUKWUNONSO NWABUFO | March 7, 2024
  • If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent
Several studies have shown that personalizing patient treatments based on their unique genotype can improve treatment outcomes, minimize adverse drug effects, and save health-care costs, writes Chukwunonso Nwabufo. Image courtesy of Pexels/Pixabay

Prescription for change: diversity’s missing link in Canada’s health-care system

  • If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent
Opinion | BY CHUKWUNONSO NWABUFO | March 7, 2024
Several studies have shown that personalizing patient treatments based on their unique genotype can improve treatment outcomes, minimize adverse drug effects, and save health-care costs, writes Chukwunonso Nwabufo. Image courtesy of Pexels/Pixabay

Prescription for change: diversity’s missing link in Canada’s health-care system

Opinion | BY CHUKWUNONSO NWABUFO | March 7, 2024
  • If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent

Prescription for change: diversity’s missing link in Canada’s health-care system

Opinion | BY CHUKWUNONSO NWABUFO | March 7, 2024
  • If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent
Several studies have shown that personalizing patient treatments based on their unique genotype can improve treatment outcomes, minimize adverse drug effects, and save health-care costs, writes Chukwunonso Nwabufo. Image courtesy of Pexels/Pixabay

COVID-19 may affect patient response to medicines

  • One of the lesser known yet critical issues arising from the disease is its potential effect on drug response and the risk of adverse
Opinion | BY CHUKWUNONSO NWABUFO | May 29, 2023
Health-care providers need to think about how COVID-19 might affect how medications work and how they might cause side effects. They can do this by adjusting medication doses and watching out for any interactions between medications, especially for people who are taking multiple drugs, writes Chukwunonso Nwabufo. Image courtesy of Pixabay

COVID-19 may affect patient response to medicines

Opinion | BY CHUKWUNONSO NWABUFO | May 29, 2023
  • One of the lesser known yet critical issues arising from the disease is its potential effect on drug response and the risk of adverse

COVID-19 may affect patient response to medicines

Opinion | BY CHUKWUNONSO NWABUFO | May 29, 2023
  • One of the lesser known yet critical issues arising from the disease is its potential effect on drug response and the risk of adverse
Health-care providers need to think about how COVID-19 might affect how medications work and how they might cause side effects. They can do this by adjusting medication doses and watching out for any interactions between medications, especially for people who are taking multiple drugs, writes Chukwunonso Nwabufo. Image courtesy of Pixabay

Don’t let the next pandemic meet this pharmaceutical sector

  • Having rounded the first year of the COVID-19 pandemic, it is interesting to see that no made-in-Canada COVID-19 medicines or vaccines have been approved
Opinion | BY CHUKWUNONSO NWABUFO | June 2, 2021
As the nation gradually recovers from the pandemic, the government should prioritize addressing the longstanding market failure in the pharmaceutical sector by providing competitive funding for research and development, writes Chukwunonso Nwabufo. Image courtesy of Pixabay

Don’t let the next pandemic meet this pharmaceutical sector

Opinion | BY CHUKWUNONSO NWABUFO | June 2, 2021
  • Having rounded the first year of the COVID-19 pandemic, it is interesting to see that no made-in-Canada COVID-19 medicines or vaccines have been approved

Don’t let the next pandemic meet this pharmaceutical sector

Opinion | BY CHUKWUNONSO NWABUFO | June 2, 2021
  • Having rounded the first year of the COVID-19 pandemic, it is interesting to see that no made-in-Canada COVID-19 medicines or vaccines have been approved
As the nation gradually recovers from the pandemic, the government should prioritize addressing the longstanding market failure in the pharmaceutical sector by providing competitive funding for research and development, writes Chukwunonso Nwabufo. Image courtesy of Pixabay
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu